China National Accord Medicines Corp Ltd (200028) — Strategic Asset Allocation Index
China National Accord Medicines Corp Ltd (200028) has a Strategic Asset Allocation Index of 17.5% as of September 2023. Strategic assets (PP&E of HK$3.58 Billion plus long-term investments of HK$-) total HK$3.58 Billion, measured against net assets of HK$20.47 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 200028 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
China National Accord Medicines Corp Ltd Strategic Asset Allocation Index (2015–2022)
This chart shows how China National Accord Medicines Corp Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of September 2023, the index stands at 17.5%, representing strategic assets of HK$3.58 Billion against net assets of HK$20.47 Billion HKD. For live market cap and overall valuation, see how much is China National Accord Medicines Corp Ltd worth.
Annual Strategic Asset Allocation Index for China National Accord Medicines Corp Ltd (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for China National Accord Medicines Corp Ltd from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 200028 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (HKD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.5% | HK$3.41 Billion | HK$3.41 Billion | HK$- | HK$19.44 Billion | ▼ -1.9 pp |
| 2021 | 19.4% | HK$3.49 Billion | HK$3.49 Billion | HK$- | HK$18.02 Billion | ▲ +0.1 pp |
| 2020 | 19.3% | HK$3.26 Billion | HK$3.26 Billion | HK$- | HK$16.89 Billion | ▲ +1.5 pp |
| 2019 | 17.8% | HK$2.73 Billion | HK$2.73 Billion | HK$- | HK$15.36 Billion | ▼ -1.5 pp |
| 2018 | 19.3% | HK$2.68 Billion | HK$644.35 Million | HK$2.03 Billion | HK$13.91 Billion | ▼ -3.3 pp |
| 2017 | 22.6% | HK$2.24 Billion | HK$574.66 Million | HK$1.66 Billion | HK$9.93 Billion | ▲ +0.6 pp |
| 2016 | 22.0% | HK$1.96 Billion | HK$534.07 Million | HK$1.43 Billion | HK$8.91 Billion | ▼ -9.7 pp |
| 2015 | 31.7% | HK$1.77 Billion | HK$1.57 Billion | HK$192.96 Million | HK$5.57 Billion | — |